Demant: Demant: Q1 sales miss; organic growth guidance unchanged

(marketscreener.com) EARNINGS/SALES RELEASESDemantÂ's Q1 sales missed the company-compiled consensus. The low-single-digit growth was led by positive contributions from Hearing Aids and Diagnostics, but Hearing Care came in flat . Operating profit was in line with the managementÂ's expectations. While the 2024 guidance was unchanged, investors were disappointed with the...https://www.marketscreener.com/quote/stock/DEMANT-A-S-56225597/news/Demant-Q1-sales-miss-organic-growth-guidance-unchanged-46638198/?utm_medium=RSS&utm_content=20240506